Heron Therapeutics Extends Tax Benefit Preservation Plan to August 2029

Heron Therapeutics, Inc. has amended its Tax Benefit Preservation Plan, effectively extending its expiration date by three years. The plan, which acts as a shareholder rights plan to protect the company's tax assets, was amended on August 13, 2026.

Key Details

• Agreement: The company entered into Amendment No. 1 to its Tax Benefit Preservation Plan, originally dated August 14, 2025.
• Extended Expiration: The plan's "Final Expiration Date" has been changed from August 14, 2026, to August 14, 2029.
• Purpose: The plan is designed to protect the company's ability to use its net operating losses and other tax benefits, which could be limited by a significant change in company ownership.